<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="letter" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">N Am Spine Soc J</journal-id><journal-id journal-id-type="iso-abbrev">N Am Spine Soc J</journal-id><journal-id journal-id-type="pmc-domain-id">4160</journal-id><journal-id journal-id-type="pmc-domain">nassj</journal-id><journal-title-group><journal-title>North American Spine Society Journal</journal-title></journal-title-group><issn pub-type="epub">2666-5484</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10205478</article-id><article-id pub-id-type="pmcid-ver">PMC10205478.1</article-id><article-id pub-id-type="pmcaid">10205478</article-id><article-id pub-id-type="pmcaiid">10205478</article-id><article-id pub-id-type="pmid">37229208</article-id><article-id pub-id-type="doi">10.1016/j.xnsj.2023.100219</article-id><article-id pub-id-type="pii">S2666-5484(23)00021-5</article-id><article-id pub-id-type="publisher-id">100219</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Letters to the Editor</subject></subj-group></article-categories><title-group><article-title>Letter to the editor regarding: development and validation of a point-of-care clinical risk score to predict surgical site infection following open spinal fusion by Mueller</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name name-style="western"><surname>Ak&#231;a</surname><given-names initials="B">Ba&#351;ak</given-names></name><degrees>M.D.</degrees><email>basak.kantar@hacettepe.edu.tr</email><xref rid="aff0001" ref-type="aff">a</xref><xref rid="cor0001" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author" id="au0002"><name name-style="western"><surname>Prus</surname><given-names initials="K">Kataryzna</given-names></name><degrees>M.D,PhD.</degrees><xref rid="aff0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au0003"><name name-style="western"><surname>Bilotta</surname><given-names initials="F">Federico</given-names></name><degrees>M.D.,PhD.</degrees><xref rid="aff0003" ref-type="aff">c</xref></contrib><aff id="aff0001"><label>a</label>Department of Anesthesiology and Reanimation, Hacettepe University School of Medicine, S&#305;hhiye, Ankara, Turkey</aff><aff id="aff0002"><label>b</label>Department of Neurology, Medical University of Lublin, Poland</aff><aff id="aff0003"><label>c</label>Department of Anesthesiology and Reanimation, Sapienza University of Rome, School of Medicine, Rome, Italy</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#8270;</label>Corresponding author at: Department of Anesthesiology, Hacettepe University Faculty of Medicine, Gevher Nesibe Cad, S&#305;hhiye, Ankara, 06100, Turkey. Tel.: +90-3123051255, fax: +90-3123109600. <email>basak.kantar@hacettepe.edu.tr</email></corresp></author-notes><pub-date pub-type="collection"><month>6</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>14</day><month>4</month><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">431193</issue-id><elocation-id>100219</elocation-id><history><date date-type="received"><day>10</day><month>3</month><year>2023</year></date><date date-type="rev-recd"><day>13</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>11</day><month>4</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>24</day><month>05</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-26 11:25:18.817"><day>26</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Authors</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><kwd-group id="keys0001"><title>Keywords</title><kwd>HbA1c</kwd><kwd>Spine surgery</kwd><kwd>Surgical site infections</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p content-type="salutation">To the Editor,</p><p id="para0004">We read with great interest the article by Mueller et&#160;al. <xref rid="bib0001" ref-type="bibr">[1]</xref> entitled &#8220;Development and validation of a point-of-care clinical risk score to predict surgical site infection following open spinal fusion&#8221; . The aim of this study was to develop and validate a surgical-site infection (SSI) risk-assessment score for patients undergoing open spine surgery.</p><p id="para0005">A database of adult open spine surgery patients was used to create an SSI risk scoring system using mixed effects logistic regression modeling. This model used 16 predictors. Sum of 16 predictors were assigned as the resulting risk score which are: female sex, hypertension, blood disorder, peripheral vascular disease, chronic pulmonary disease, rheumatic disease, obesity, diabetes, nicotine dependence, Charlson Comorbidity Index, revision surgery, number of ICD-10 procedures, operative time and emergent surgery. The authors concluded that the resulting SSI risk score composed of readily obtainable clinical information could serve as a strong prediction tool for SSI in preoperative settings when open spine surgery is considered. There is major point to be discussed further.</p><p id="para0006">Diabetes mellitus (DM) is a chronic systemic disease known to have several major consequences on major vital systems of the organisms. HbA1c is an indicator used to determine the measure of average blood glucose levels for the last 3 months and therefore is used as the gold-standard parameter for predicting the relative risk of diabetes complications <xref rid="bib0002" ref-type="bibr">[2]</xref>.</p><p id="para0007">Tracking the HbA1c changes in time, which is also associated with certain risks, could warn the clinicians about the potential complications. In a very recent trial, Scott et&#160;al. <xref rid="bib0003" ref-type="bibr">[3]</xref> concluded that there is an increased risk of complication occurrence by increasing variability of HbA1c for both microvascular and macrovascular endpoints.</p><p id="para0008">The American Diabetes Association is currently recommending to keeping HbA1c levels below 7.0 prior to elective surgery for optimal reduction of postoperative complications <xref rid="bib0004" ref-type="bibr">[4]</xref>. There are also some very important articles mentioning the optimal HbA1c levels regarding SSI rates in neurosurgical practice [<xref rid="bib0005" ref-type="bibr">5</xref>,<xref rid="bib0006" ref-type="bibr">6</xref>]. These trials are indicating a threshold of HbA1c values that a clinician should focus on during preoperative assessment of neurosurgical patients and HbA1c levels above these thresholds are concluded to be associated with worse outcomes like SSI.</p><p id="para0009">Given the above mentioned concerns and the relevance of HbA1c with major/ minor complications in patients undergoing spine surgery is it possible to adhere HbA1c as a major risk stratification parameter and analyze regarding SSI after spine surgery which means evaluating a diabetic patient thoroughly?</p><p id="para0010">We believe that clarification of this issue will improve the anesthetic management of patients undergoing spine surgery.</p><sec sec-type="COI-statement"><title>Declarations of Competing Interests</title><p id="para0011">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><label>1</label><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><name name-style="western"><surname>Mueller</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Beach</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Development and validation of a point-of-care clinical risk score to predict surgical site infection following open spinal fusion</article-title><source>N Am Spine Soc J</source><volume>13</volume><year>2023</year><fpage>100196</fpage><pub-id pub-id-type="pmid">36691580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xnsj.2022.100196</pub-id><pub-id pub-id-type="pmcid">PMC9860512</pub-id></element-citation></ref><ref id="bib0002"><label>2</label><element-citation publication-type="journal" id="sbref0002"><person-group person-group-type="author"><name name-style="western"><surname>Battelino</surname><given-names>T.</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Amiel</surname><given-names>S.A.</given-names></name><etal/></person-group><article-title>Continuous glucose monitoring and metrics for clinical trials: an international consensus statement</article-title><source>Lancet Diabetes Endocrinol</source><volume>11</volume><issue>1</issue><year>2023</year><fpage>42</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">36493795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(22)00319-9</pub-id></element-citation></ref><ref id="bib0003"><label>3</label><element-citation publication-type="journal" id="sbref0002a1"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Januszewski</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>O'Connell</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Long-term glycemic variability and vascular complications in type 2 diabetes: post hoc analysis of the FIELD study</article-title><source>J Clin Endocrinol Metab</source><volume>105</volume><issue>10</issue><year>2020</year><fpage>e3638</fpage><lpage>e3649</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/clinem/dgaa361</pub-id><pub-id pub-id-type="pmid">32766757</pub-id></element-citation></ref><ref id="bib0004"><label>4</label><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><collab>American Diabetes, A.&#8239;</collab></person-group><article-title>Glycemic targets: standards of medical care in diabetes-2020</article-title><source>Diabetes Care</source><volume>43</volume><issue>Suppl 1</issue><year>2020</year><fpage>S66</fpage><lpage>S76</lpage><pub-id pub-id-type="pmid">31862749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc20-S006</pub-id></element-citation></ref><ref id="bib0005"><label>5</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Chanbour</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Optimal hemoglobin A1C target in diabetics undergoing elective cervical spine surgery</article-title><source>Spine J</source><volume>22</volume><issue>7</issue><year>2022</year><fpage>1149</fpage><lpage>1159</lpage><pub-id pub-id-type="pmid">35257839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.spinee.2022.02.014</pub-id></element-citation></ref><ref id="bib0006"><label>6</label><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name name-style="western"><surname>Kulikov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Krovko</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nikitin</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Severe intraoperative hyperglycemia and infectious complications after elective brain neurosurgical procedures: prospective observational study</article-title><source>Anesth Analg</source><volume>135</volume><issue>5</issue><year>2022</year><fpage>1082</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">35051950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0000000000005912</pub-id></element-citation></ref></ref-list><fn-group><fn id="d35e16"><p id="notep0001">FDA device/drug status: Not applicable.</p></fn><fn id="d35e19"><p id="notep0002">Author disclosures: <bold><italic toggle="yes">BA:</italic></bold> Nothing to disclose. <bold><italic toggle="yes">KP:</italic></bold> Nothing to disclose. <bold><italic toggle="yes">FB:</italic></bold> Nothing to disclose.</p></fn></fn-group></back></article></pmc-articleset>